Challenges and Solutions in Animal-Free Neurotoxicity Assays

A review analysis of animal-derived components in human cell-based developmental neurotoxicity assays. The dataset was authored by Julia Vanessa Spänle and last updated on May 11, 2026. It examines basal media, supplements, extracellular matrix, growth factors, and antibodies used in the Developmental Neurotoxicity in vitro Battery.

Use Cases

• Identify animal-derived components in cell-based assays based on the described materials analysis.
• Develop strategies for transitioning to animal-free protocols based on the proposed two-pronged approach.
• Evaluate the implementation of guidance documents like OECD GIVIMP and GCCP in specific assay components.
• Inform manufacturers on labeling and product development for animal-free cell culture reagents.

Strengths

• Focuses on a specific and current challenge in toxicology: replacing animal-derived components in the DNT-IVB.
• Provides actionable strategies for both new protocol design and established assay evaluation.
• Cites specific guidance documents (OECD GIVIMP, GCCP, EURL ECVAM recommendations).

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• The dataset is small (14.4 KB), indicating a limited scope, likely a summary table.

Provenance

Source

figshare

Collection Method

Review and analysis of existing protocols and components.

Freshness

Last updated 2026-05-11 22:02:41; freshness should be verified.